O'Donnell M A
Harvard Medical School, Beth Israel Deaconess Medical Center, Division of Urology, Boston, MA 02215, USA.
Trends Biotechnol. 1997 Dec;15(12):512-7. doi: 10.1016/S0167-7799(97)01134-7.
The bacillus of Calmette and Guérin (BCG), long appreciated for its role as a live vaccine for the prevention of tuberculosis, is undergoing a rebirth as a recombinant delivery vehicle for foreign antigens and bioactive proteins. Recombinant BCG causes long-lived specific humoral and cellular immunity and may ultimately prove to be a powerful and cost-effective new weapon against both infectious pathogens and certain cancers.